The decision has impacted “some of our employees,” a BMS spokesperson said, without disclosing expected layoff numbers. (Bristol Myers Squibb) Roughly two years after securing a former Novartis ...
The 2seventy transaction "gives BMS full freedom to operate, improves efficiencies, and ensures appropriate business continuity" for the cell therapy Abecma, Lynelle Hoch, president of Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results